WFSBP 2019 Preliminary Program

16 WFSBP 2019 Preliminary Scientific Program / Symposia T1: ADDICTIVE DISORDERS S-05 08:15–09:45 Opiate agonist therapies: Drugs, modes of application and clinical targets Chair: Daniele Zullino, Switzerland Co-Chair: Marc Vogel, Switzerland S-05-001 Drugs and modes of application Marc Vogel, Switzerland S-05-002 Clinical targets of opiate agonists Daniele Zullino, Switzerland S-05-003 Slow-release oral morphine’s acute effect on impulsivity and risk-taking Laura Colombo, Switzerland S-05-004 Opiate agonist’s effects on comorbidities Amine Benyamina, Switzerland T2: ADHD S-06 08:15–09:45 Comorbidity of adult ADHD and treatment-resistant depression: Augmentation with methylphenidate Chair: Srinivas Kandrakonda, India Co-Chair: Sravana Sandya Penugonda, India S-06-001 Complexities of managing A-ADHD and comorbidities: A factor analysis Sravana Sandya Penugonda, India S-06-002 A-ADHD and other psychiatric disorders: Prevalence and incidence in Indian populations Siva Kumar Chenamasetty, India S-06-003 A-ADHD and internet addiction: A cross-sectional analysis Rajender Soorineedu, India S-06-004 Pleomorphic representations of A-ADHD and comorbidities Vikram Akavaram, India T7: BIPOLAR DISORDERS: BASIC/CLINICAL S-82 08:15–09:45 Epidemiological, socio-demographic, clinical and therapeutic differences in Bipolar Disorders among different countries Chair: Terence Ketter, USA Co-Chair: Bernardo Dell’Osso, Italy S-82-001 Preliminary results of the Italian multicentre RENDIBI study Bernardo Dell’Osso, Italy S-82-002 Differences in Bipolar 1 vs 2 disorders in American vs Italian patients: The Milan-Stanford collaborative study Terence Ketter, USA S-82-003 Bipolar disorders in South and North America: A com- parative study Gustavo Vazquez, Canada S-82-004 Bipolar Disorder: More difficult and complicated in the U.S. Robert Post, USA T7: BIPOLAR DISORDERS: BASIC/CLINICAL S-07 11:30–13:00 What’s up with mixed states in Bipolar Disorder (BD) and Major Depression? Chair: Trisha Suppes, USA Co-Chair: Heinz Grunze, Germany S-07-001 A single WFSBP guideline across mixed states – a viable approach? Heinz Grunze, Germany S-07-002 Mixed states in the clinical arena Eduard Vieta, Spain S-07-003 Treatment studies in mixed states Trisha Suppes, USA S-07-004 Is obesity changing the phenotype of BD toward mixed states?: Implications for disease models and Rx Roger McIntyre, Canada MON